Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Key Stats

In Millions of the trading currency, except per share items. Currency: Order: Decimals: Trading Currency Latest on Right Capital IQ (Default) Conversion: Units: Today's Spot Rate Capital IQ (Default)

Key Financials For the Fiscal Period Ending Currency Total Revenue Growth Over Prior Year Gross Profit Margin % EBITDA Margin % EBIT Margin % Earnings from Cont. Ops. Margin % Net Income Margin % Diluted EPS Excl. Extra Items Growth Over Prior Year 12 months Dec-31-2006A SGD 20.3 NA 5.2 25.7% 1.0 4.9% 0.7 3.6% 1.0 4.9% 1.0 4.9% 0.697 NA 12 months Dec-31-2007A SGD 42.8 110.9% 14.0 32.6% 6.6 15.4% 6.2 14.5% 5.6 13.1% 5.6 13.1% 3.968 469.4% 12 months Dec-31-2008A SGD 80.9 89.0% 27.6 34.1% 13.8 17.1% 13.0 16.1% 9.6 11.8% 9.6 11.8% 0.013 (99.7%) 12 months Dec-31-2009A SGD 98.6 21.8% 32.7 33.2% 20.1 20.4% 19.2 19.4% 15.2 15.5% 15.2 15.5% 0.011 (14.5%) 12 months Dec-31-2010A SGD 86.5 (12.2%) 17.2 19.9% 6.1 7.0% 4.8 5.6% 2.8 3.3% 2.8 3.3% 0.002 (85.4%)

All results are taken from the most recently filed statement for each period. When there has been more than one, earlier filings can be viewed on the individual statement pages. Growth rates for the LTM period are calculated against the LTM period ending 12 months before.

Current Capitalization (Millions of SGD) Currency Share Price as of Aug-05-2011 Shares Out. Market Capitalization**

SGD 0.09 2,075.7 176.4

- Cash & Short Term Investments + Total Debt + Pref. Equity + Total Minority Interest = Total Enterprise Value (TEV) Book Value of Common Equity + Pref. Equity + Total Minority Interest + Total Debt = Total Capital **For companies that have multiple share classes that publicly trade, we are incorporating the different prices to calculate our company level market capitalization. Please click on the value to see the detailed calculation. Prices shown on this page are the close price of the companys primary stock class. Shares shown on this page are total company as-reported share values.

7.7 32.5 201.2 194.8 32.5 227.3

Total Liability includes Total Debt, Minority Interest and Pref. Equity. Net Liability includes Total Liability, net of Cash and Short Term Investments. TEV includes Market Cap and Net Liability. Total Capital includes Common Equity and Total Liability. Valuation Multiples based on Current Capitalization

For the Fiscal Period Ending TEV/Total Revenue TEV/EBITDA TEV/EBIT P/Diluted EPS Before Extra P/BV Price/Tang BV

12 months Dec-31-2007A 4.7x 29.4x 31.3x 0.0x 0.0x NM

12 months Dec-31-2008A 2.5x 14.5x 15.4x 6.5x 0.9x NM

12 months Dec-31-2009A 2.0x 10.0x 10.5x 7.6x 0.8x NM

12 months Dec-31-2010A 2.2x 31.6x 39.9x 52.0x 0.8x 9.9x

LTM 12 months Mar-31-2011A 2.4x 31.6x 40.1x 52.2x 0.8x 9.2x

Financial data provided by

LTM 12 months Mar-31-2011A SGD 84.7 (12.7%) 17.4 20.6% 6.4 7.5% 5.0 5.9% 3.0 3.5% 3.0 3.5% 0.002 (82.3%)

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Income Statement
In Millions of the reported currency, except per share items. Template: Period Type: Currency: Units: Standard Annual Reported Currency Capital IQ (Default) Restatement: Order: Conversion: Decimals: Latest Filings Latest on Right Today's Spot Rate Capital IQ (Default)

Income Statement For the Fiscal Period Ending Currency Revenue Other Revenue Total Revenue Cost Of Goods Sold Gross Profit Selling General & Admin Exp. R & D Exp. Depreciation & Amort. Amort. of Goodwill and Intangibles Other Operating Expense/(Income) Other Operating Exp., Total Operating Income Interest Expense Interest and Invest. Income Net Interest Exp. Income/(Loss) from Affiliates Other Non-Operating Inc. (Exp.) EBT Excl. Unusual Items Impairment of Goodwill Gain (Loss) On Sale Of Assets Other Unusual Items EBT Incl. Unusual Items 12 months Dec-31-2006 SGD 20.3 20.3 15.1 5.2 0.2 0.1 4.2 4.5 0.7 0 0.0 0 0.5 1.2 1.2 Reclassified 12 months Dec-31-2007 SGD 42.8 42.8 28.8 14.0 0.4 0.0 7.3 7.8 6.2 (0.2) (0.2) 0.2 6.2 6.2 Reclassified 12 months Dec-31-2008 SGD 80.9 80.9 53.3 27.6 0.8 0.0 13.8 14.6 13.0 (1.4) 0.1 (1.3) 11.8 0.0 11.8 12 months Dec-31-2009 SGD 98.6 98.6 65.9 32.7 0.9 0.0 12.6 13.6 19.2 (1.5) 0.1 (1.4) 17.8 0 17.7 12 months Dec-31-2010 SGD 86.5 86.5 69.3 17.2 1.3 0.0 11.1 12.4 4.8 (1.5) 0.1 (1.4) (0.1) 3.3 0 3.3

Income Tax Expense Earnings from Cont. Ops. Earnings of Discontinued Ops. Extraord. Item & Account. Change Net Income to Company Minority Int. in Earnings Net Income Pref. Dividends and Other Adj. NI to Common Incl Extra Items NI to Common Excl. Extra Items Per Share Items Basic EPS Basic EPS Excl. Extra Items Weighted Avg. Basic Shares Out. Diluted EPS Diluted EPS Excl. Extra Items Weighted Avg. Diluted Shares Out. Normalized Basic EPS Normalized Diluted EPS Dividends per Share Payout Ratio % Supplemental Items EBITDA EBITA EBIT EBITDAR Effective Tax Rate % Current Domestic Taxes Total Current Taxes Deferred Domestic Taxes Total Deferred Taxes Normalized Net Income Filing Date Restatement Type Calculation Type

0.2 1.0 1.0 1.0 1.0 1.0

0.6 5.6 5.6 5.6 5.6 5.6

2.3 9.6 9.6 9.6 9.6 9.6

2.5 15.2 15.2 15.2 15.2 15.2

0.4 2.8 2.8 2.8 2.8 2.8

0.697 0.697 1.4 0.697 0.697 1.4 0.531 0.531 NA NA

3.968 3.968 1.4 3.968 3.968 1.4 2.76 2.76 NA NA

0.013 0.013 731.9 0.013 0.013 731.9 0.01 0.01 0.0 NA

0.011 0.011 1,365.1 0.011 0.011 1,365.1 0.008 0.008 0.0 3.5%

0.002 0.002 1,732.4 0.002 0.002 1,732.4 0.001 0.001 NA 13.7%

1.0 0.7 0.7 3.7 17.9% 0.2 0.2 NA 0.7 Jun-26-2008 O ANNU

6.6 6.2 6.2 11.4 10.2% 0.9 0.9 (0.2) (0.2) 3.9 Apr-20-2009 RC REP

13.8 13.0 13.0 21.6 19.1% 1.9 1.9 0.4 0.4 7.4 Apr-13-2010 RC REP

20.1 19.2 19.2 28.5 14.1% 2.5 2.5 NA 11.1 Apr-14-2011 NC REP

6.1 4.8 4.8 17.1 13.4% NA 0.6 NA (0.2) 2.1 Apr-14-2011 O REP

Supplemental Operating Expense Items Net Rental Exp. Imputed Oper. Lease Interest Exp. Imputed Oper. Lease Depreciation

2.7 -

4.8 3.5 1.3

7.8 2.3 5.5

8.5 1.5 7.0

11.1 2.7 8.4

Note: For multiple class companies, per share items are primary class equivalent, and for foreign companies listed as primary ADRs, per share items are ADR-equivalent.

Financial data provided by

LTM 12 months Mar-31-2011 SGD 84.7 84.7 67.3 17.4 1.3 0.1 11.0 12.4 5.0 (1.4) 0.1 (1.3) (0.1) 3.6 0 3.6

0.6 3.0 3.0 3.0 3.0 3.0

0.002 0.002 1,820.1 0.002 0.002 1,820.1 0.001 0.001 NA 13.1%

6.4 5.1 5.0 NA 16.9% NA 0.6 NA (0.2) 2.2 May-13-2011 O LTM

NA -

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Balance Sheet
In Millions of the reported currency, except per share items. Template: Period Type: Currency: Units: Standard Annual Reported Currency Capital IQ (Default) Restatement: Order: Conversion: Decimals: Latest Filings Latest on Right Today's Spot Rate Capital IQ (Default)

Balance Sheet Balance Sheet as of: Currency ASSETS Cash And Equivalents Short Term Investments Total Cash & ST Investments Accounts Receivable Other Receivables Total Receivables Inventory Prepaid Exp. Other Current Assets Total Current Assets Gross Property, Plant & Equipment Accumulated Depreciation Net Property, Plant & Equipment Long-term Investments Goodwill Other Intangibles Loans Receivable Long-Term Deferred Tax Assets, LT Other Long-Term Assets Total Assets LIABILITIES Accounts Payable Accrued Exp. Short-term Borrowings Curr. Port. of LT Debt Curr. Port. of Cap. Leases Dec-31-2006 SGD 0.8 0.7 1.5 2.0 0.6 2.6 0.9 0.0 5.0 3.6 (2.0) 1.6 0.5 0.9 8.1 16.1 Dec-31-2007 SGD 6.6 1.3 7.9 3.8 1.8 5.6 2.5 0.5 2.0 18.4 5.4 (2.4) 3.0 74.7 8.1 0.2 104.5 Dec-31-2008 SGD 28.9 1.6 30.5 6.5 1.3 7.8 3.3 0.3 41.9 7.0 (2.8) 4.2 149.1 27.4 222.6 Dec-31-2009 SGD 28.5 2.3 30.8 7.9 2.1 10.0 3.7 0.2 44.7 8.8 (3.7) 5.1 149.1 27.4 3.3 229.5 Dec-31-2010 SGD 18.9 1.7 20.6 6.1 4.0 10.1 3.0 0.8 34.5 11.1 (4.4) 6.7 149.1 28.5 22.8 0.1 241.6

2.7 0.5 0.4 1.0 -

4.8 2.6 0.1 2.1 0.0

6.8 2.9 4.4 38.8 0.0

7.7 4.3 0.4 19.3 0.5

5.5 3.9 1.5 18.9 0.4

Curr. Income Taxes Payable Unearned Revenue, Current Other Current Liabilities Total Current Liabilities Long-Term Debt Capital Leases Def. Tax Liability, Non-Curr. Other Non-Current Liabilities Total Liabilities Common Stock Additional Paid In Capital Retained Earnings Treasury Stock Comprehensive Inc. and Other Total Common Equity Total Equity Total Liabilities And Equity Supplemental Items Total Shares Out. on Filing Date Total Shares Out. on Balance Sheet Date Book Value/Share Tangible Book Value Tangible Book Value/Share Total Debt Net Debt Debt Equivalent Oper. Leases Equity Method Investments Inventory Method Machinery Leasehold Improvements Full Time Employees Accum. Allowance for Doubtful Accts Filing Date Restatement Type Calculation Type

0.2 0.1 5.0 9.9 5.4 15.3 0.8 0.8 0.8 16.1

1.5 0.8 1.4 13.4 0.6 0.1 84.0 98.1 0.0 6.4 6.4 6.4 104.5

3.5 1.4 57.8 28.5 0.4 0.1 0.4 87.2 119.4 16.0 135.4 135.4 222.6

2.8 1.5 36.5 42.4 0.9 0.1 0.4 80.3 121.9 27.9 (0.6) 149.2 149.2 229.5

0.3 2.0 32.4 15.2 0.2 0.4 48.2 168.2 28.6 (3.0) (0.3) 193.4 193.4 241.6

1.4 1.4 0.58 (8.2) (5.8) 1.4 0 22.0 0.5 NA 2.0 1.5 NA 0.0 Jun-26-2008 O REP

1.4 1.4 4.55 (76.4) (54.11) 2.9 (5.0) 38.3 NA Avg Cost 3.3 1.9 441 0.0 Apr-20-2009 NC REP

1,373.4 1,373.4 0.1 (41.1) (0.03) 72.1 41.6 62.2 NA Avg Cost 4.2 2.7 480 0.2 Apr-13-2010 NC REP

1,379.8 1,379.8 0.11 (27.3) (0.02) 63.5 32.8 67.7 NA Avg Cost 5.5 3.2 NA 0.2 Apr-14-2011 NC REP

1,845.1 1,845.1 0.1 15.8 0.01 36.2 15.6 88.5 NA Avg Cost 7.3 3.7 NA 1.0 Apr-14-2011 O REP

Note: For multiple class companies, total share counts are primary class equivalent, and for foreign companies listed as primary ADRs, total share counts are ADR-equivalent.

Financial data provided by

Mar-31-2011 SGD 7.7 7.7 18.7 18.7 3.2 29.5 6.8 177.7 23.5 0.1 237.6

9.6 17.1 0.4

0.4 27.5 14.8 0.2 0.4 42.8 168.2 30.1 (3.0) (0.5) 194.8 194.8 237.6

1,845.1 1,845.1 0.11 17.0 0.01 32.5 24.8 NA NA NA NA NA NA May-13-2011 O REP

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Cash Flow
In Millions of the reported currency, except per share items. Template: Period Type: Currency: Units: Standard Annual Reported Currency Capital IQ (Default) Restatement: Order: Conversion: Decimals: Latest Filings Latest on Right Today's Spot Rate Capital IQ (Default)

Cash Flow For the Fiscal Period Ending Currency Net Income Depreciation & Amort. Amort. of Goodwill and Intangibles Depreciation & Amort., Total Other Amortization (Gain) Loss From Sale Of Assets Asset Writedown & Restructuring Costs (Income) Loss on Equity Invest. Other Operating Activities Change in Acc. Receivable Change In Inventories Change in Acc. Payable Change in Other Net Operating Assets Cash from Ops. Capital Expenditure Sale of Property, Plant, and Equipment Cash Acquisitions Divestitures Sale (Purchase) of Intangible assets Invest. in Marketable & Equity Securt. Net (Inc.) Dec. in Loans Originated/Sold Other Investing Activities Cash from Investing Short Term Debt Issued Long-Term Debt Issued Total Debt Issued Short Term Debt Repaid 12 months Dec-31-2006 SGD 1.0 0.2 0.2 0.1 0.0 (0.5) 0.3 0.2 (0.2) 1.6 2.7 (0.9) 1.1 0 0.2 0.0 0.3 1.2 1.2 12 months Dec-31-2007 SGD 5.6 0.4 0.4 0.0 0.1 (0.2) 0.8 (2.7) (1.3) 2.2 5.0 (0.6) (20.7) (0.1) 0.6 0.0 (20.7) 26.9 26.9 (0.4) 12 months Dec-31-2008 SGD 9.6 0.8 0.8 0.0 0 1.4 9.5 (0.3) (1.1) 19.9 (1.7) 0.1 (15.0) 0.1 (16.5) 21.3 21.3 (34.7) 12 months Dec-31-2009 SGD 15.2 0.9 0.9 0.0 0.0 0.7 (2.7) (0.4) 1.8 15.5 (0.8) 0.0 (3.2) (3.9) 26.5 26.5 (3.4) 12 months Dec-31-2010 SGD 2.8 1.3 1.3 0.0 (4.0) (1.4) (1.4) (2.1) 0.3 2.3 (2.2) (5.1) 0.0 0.2 1.9 (1.1) (17.4) 0.1 (21.5) 12.8 12.8 -

Long-Term Debt Repaid Total Debt Repaid Issuance of Common Stock Repurchase of Common Stock Common Dividends Paid Total Dividends Paid Special Dividend Paid Other Financing Activities Cash from Financing Net Change in Cash Supplemental Items Cash Interest Paid Cash Taxes Paid Levered Free Cash Flow Unlevered Free Cash Flow Change in Net Working Capital Net Debt Issued Filing Date Restatement Type Calculation Type

(1.7) (1.7) (1.6) (2.1) 0.9

(0.7) (1.1) 0.0 (4.4) 21.4 5.7

(0.6) (35.3) 34.4 (22.4) (1.9) 1.4

(32.2) (35.6) (0.5) (0.5) (1.8) (11.4) 0.2

(39.3) (39.3) 45.3 (3.0) (0.4) (0.4) 17.3 32.7 9.0

0.0 NA NA NA NA (0.5) Jun-26-2008 O ANNU

0.2 0.0 (0.9) (0.7) 4.4 25.8 Apr-20-2009 NC REP

1.4 2.2 9.1 9.9 (2.6) (13.9) Apr-13-2010 NC REP

1.5 3.2 10.3 11.3 0.8 (9.1) Apr-14-2011 NC REP

1.5 3.3 (7.6) (6.6) 4.7 (26.5) Apr-14-2011 O REP

Financial data provided by

LTM 12 months Mar-31-2011 SGD 3.0 1.3 0.1 1.4 0.0 (4.0) (1.4) (1.2) (3.9) 0.2 2.5 (3.5) (2.4) 0.0 0.2 1.9 (1.1) (18.1) 0.4 (19.0) 7.4 -

(39.7) 24.7 (0.5) (0.4) (0.4) 18.2 9.8 (12.8)

1.4 2.8 (4.5) (3.7) 4.8 (32.3) May-13-2011 O LTM

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Multiples

View: Order: Data Latest on Right Frequency: Decimals: Quarterly Capital IQ (Default)

Multiples Detail For Quarter Ending TEV/LTM Total Revenue Dec-31-2009 2.15x 2.28x 2.04x 2.25x 9.46x 10.26x 8.87x 9.76x 9.85x 10.66x 9.25x 10.18x 12.56x 14.03x 11.48x 12.92x 14.49x 15.85x 13.45x 15.13x 1.21x 1.31x 1.13x 1.27x NM NM NM NM Mar-31-2010 2.86x 3.36x 2.24x 3.10x 13.09x 16.53x 9.72x 15.25x 13.69x 17.34x 10.13x 16.00x 15.36x 18.18x 12.92x 14.78x 19.15x 22.17x 15.13x 20.32x 1.54x 1.79x 1.27x 1.53x NM NM NM NM Jun-30-2010 3.28x 4.14x 2.83x 3.86x 17.46x 23.37x 13.90x 21.77x 18.42x 24.77x 14.57x 23.07x 16.52x 22.30x 12.99x 20.67x 22.91x 31.15x 17.83x 28.87x 1.57x 2.00x 1.34x 1.86x NM NM NM NM Sep-30-2010 3.67x 3.98x 3.34x 3.54x 26.37x 31.98x 20.85x 31.11x 28.85x 35.70x 22.10x 34.74x 25.41x 31.26x 19.58x 30.39x 39.69x 52.16x 27.35x 50.71x 1.74x 1.90x 1.57x 1.66x 19.94x 20.76x 19.03x 20.18x

Average High Low Close Average High Low Close Average High Low Close Average High Low Close Average High Low Close Average High Low Close Average High Low Close

TEV/LTM EBITDA

TEV/LTM EBIT

P/LTM EPS

P/LTM Normalized EPS

P/BV

P/Tangible BV

TEV/LTM Unlevered FCF

Average High Low Close Average High Low Close

11.97x 15.48x 7.64x 15.48x 10.90x 14.41x 6.65x 14.41x

32.22x 58.43x 15.41x 53.90x 33.04x 62.55x 14.34x 57.13x

32.94x 55.35x 24.73x NM 33.12x 58.86x 23.79x NM

NM NM NM NM NM NM NM NM

Market Cap/LTM Levered FCF

Average multiples are calculated using positive close values on each trading day within the frequency periods selected. Negative values are excluded from the calculation. When the Multiples are not meaningful, due to

When a mismatch exists between the currency of the equity listing and the reported financial results such results are translated into the currency of the listing at the exchange rate applicable on the financial period end d

Financial data provided by

Historical Equity Pricing Data supplied by

Dec-31-2010 3.28x 3.66x 3.05x 3.46x 33.23x 41.27x 26.80x 39.02x 38.16x 48.26x 29.92x 45.63x 39.38x 54.93x 26.05x 51.79x 59.80x 79.44x 43.47x 74.90x 1.51x 1.68x 1.39x 1.58x 18.79x 21.25x 17.30x 20.04x

Mar-31-2011 3.13x 3.46x 2.87x 2.97x 36.11x 39.02x 32.28x NM 42.23x 45.63x 37.75x NM 60.05x 85.89x 42.37x 79.75x 69.02x 74.90x 61.28x NM 1.38x 1.58x 1.19x 1.24x 17.32x 20.04x 14.56x 15.14x

Jun-30-2011 2.75x 3.12x 2.25x 2.62x 36.79x 43.49x 29.96x 34.85x 46.63x 55.05x 38.02x 44.22x 70.40x 82.82x 55.25x 58.32x 92.11x 113.92x 73.17x 77.24x 1.09x 1.29x 0.85x 0.90x 12.92x 15.72x 9.75x 10.29x

Aug-08-2011 2.48x 2.62x 2.15x 2.15x 32.98x 34.85x 28.66x 28.66x 41.85x 44.22x 36.36x 36.36x 54.79x 58.32x 46.65x 46.65x 72.57x 77.24x 61.79x 61.79x 0.85x 0.90x 0.72x 0.72x 9.67x 10.29x 8.23x 8.23x

NM NM NM NM NM NM NM NM

NM NM NM NM NM NM NM NM

NM NM NM NM NM NM NM NM

NM NM NM NM NM NM NM NM

Multiples are not meaningful, due to negative values, then they will not be displayed in the chart.

pplicable on the financial period end date.

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Historical Capitalization
In Millions of the trading currency, except per share items. Frequency: Currency: Units: Quarterly Trading Currency Capital IQ (Default) Order: Conversion: Decimals: Latest on Right Today's Spot Rate Capital IQ (Default)

Historical Capitalization Balance Sheet as of Pricing as of* Currency Capitalization Detail Share Price Shares Out. Market Capitalization - Cash & Short Term Investments + Total Debt + Pref. Equity + Total Minority Interest = Total Enterprise Value (TEV) Book Value of Common Equity + Pref. Equity + Total Minority Interest + Total Debt = Total Capital Dec-31-2009 Apr-13-2010 SGD 0.16 1,641.7 270.9 30.8 63.5 303.6 149.2 63.5 212.7 Mar-31-2010 May-14-2010 SGD 0.15 1,832.0 274.8 39.4 66.1 301.5 168.1 66.1 234.2 Jun-30-2010 Aug-16-2010 SGD 0.18 1,845.1 332.1 32.6 42.5 341.9 192.9 42.5 235.3 Sep-30-2010 Nov-12-2010 SGD 0.15 1,845.1 286.0 22.8 38.7 301.9 192.7 38.7 231.4 Dec-31-2010 Apr-14-2011 SGD 0.13 1,845.1 239.9 20.6 36.2 255.5 193.4 36.2 229.6

* Pricing as of the filing date of the balance sheet period end date. For TEV calculation purposes on this page Capital IQ only uses balance sheet components from the original filing that is publicly available as of a given pricing date and does not use restated balance sheet data from a later filing. In the cases where a company did not disclose balance sheet values for a particular period, TEV is calculated using balance sheet components from the last reported balance sheet as of this date. The table above is organized along period end dates.

** For companies that have multiple share classes that publicly trade, we are incorporating the different prices to calculate our company level market capitalization. Please click on the value to see the detailed calculation. Prices shown on this page are the close price of the companys primary stock class. Shares shown on this page are total company as-reported share values.

Financial data provided by

Historical Equity Pricing Data supplied by

zation

Mar-31-2011 May-13-2011 SGD 0.13 1,845.1 239.9 7.7 32.5 264.6 194.8 32.5 227.3

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Capital Structure Summary
In Millions of the reported currency, except ratios and % of Total values. Restatement: Currency: Units: Order: Latest Filings Reported Currency Capital IQ (Default) Latest on Right Period Type: Conversion: Decimals: Annual Today's Spot Rate Capital IQ (Default)

Capital Structure Data For the Fiscal Period Ending Currency Units Total Debt Total Common Equity Total Capital 12 months Dec-31-2009 SGD Millions % of Total 63.5 149.2 212.7 29.9% 70.1% 100.0% 12 months Dec-31-2010 SGD Millions % of Total 36.2 193.4 229.6 15.8% 84.2% 100.0% 3 months Mar-31-2011 SGD Millions 32.5 194.8 227.3

Currency Exchange Rate Conversion Method

SGD 1.0 S

SGD 1.0 S

SGD 1.0 S

Debt Summary Data For the Fiscal Period Ending Currency Units Total Revolving Credit Total Term Loans Total Capital Leases Total Principal Due Total Adjustments Total Debt Outstanding Additional Totals Total Cash & ST Investments Net Debt Total Senior Debt Total Short-Term Borrowings Curr. Port. of LT Debt/Cap. Leases 12 months Dec-31-2009 SGD Millions % of Total 0.4 61.7 1.4 63.5 63.5 0.7% 97.2% 2.2% 100.0% 100.0% 12 months Dec-31-2010 SGD Millions % of Total 8.4 27.1 0.6 36.2 36.2 23.2% 75.0% 1.7% 100.0% 100.0% 3 months Mar-31-2011 SGD Millions 1.2 0.6 1.8 30.7 32.5

30.8 32.8 63.5 0.4 19.8

100.0% 0.7% 31.1%

20.6 15.6 36.2 1.5 19.3

100.0% 4.0% 53.3%

7.7 24.8 1.8 17.5

Long-Term Debt (Incl. Cap. Leases) Total Bank Debt Total Secured Debt Senior Secured Loans Total Senior Secured Debt Total Unsecured Debt Fixed Rate Debt Variable Rate Debt Credit Ratios Net Debt/EBITDA Total Debt/EBITDA Total Senior Debt/EBITDA Total Senior Secured/EBITDA Net Debt/(EBITDA-CAPEX) Total Debt/(EBITDA-CAPEX) Total Senior Debt/(EBITDA-CAPEX) Total Senior Secured/(EBITDA-CAPEX) Fixed Payment Schedule LT Debt (Incl. Cap. Leases) Due +1 LT Debt (Incl. Cap. Leases) Due +2 LT Debt (Incl. Cap. Leases) Due +3 LT Debt (Incl. Cap. Leases) Due +4 LT Debt (Incl. Cap. Leases) Due +5 LT Debt (Incl. Cap. Leases) Due, Next 5 Yrs Cap. Lease Payment Due +1 Cap. Lease Payment Due +2 Cap. Lease Payment Due +3 Cap. Lease Payment Due +4 Cap. Lease Payment Due +5 Cap. Lease Payment Due, Next 5 Yrs Cap. Lease Payment Due, After 5 Yrs Cap. Lease Payment Due (incl. Interest) +1 Operating Lease Commitment Due +1 Operating Lease Commitment Due +2 Operating Lease Commitment Due +3 Operating Lease Commitment Due +4 Operating Lease Commitment Due +5 Operating Lease Commitment Due, Next 5 Yrs Sub-Lease Income +1 Sub-Lease Income +2 Sub-Lease Income +3

43.3 62.1 51.6 50.3 51.6 11.9 1.8 61.7

68.2% 97.8% 81.3% 79.1% 81.3% 18.7% 2.8% 97.2%

15.4 35.5 16.9 16.3 16.9 19.3 2.1 23.6

42.6% 98.3% 46.8% 45.0% 46.8% 53.2% 5.8% 65.2%

15.0 1.2 1.8 1.2 1.8 1.8 -

1.6x 3.2x 3.2x 2.6x 1.7x 3.3x 3.3x 2.7x

2.6x 5.9x 5.9x 2.8x 16.6x 38.5x 38.5x 18.0x

2.7x 3.5x 0.2x 0.2x 3.2x 4.2x 0.2x 0.2x

19.8 10.8 10.8 10.8 10.8 63.1 0.5 0.2 0.2 0.2 0.2 1.4 8.7 5.9 5.9 20.5 0.1 0.1 0.1

31.1% 17.0% 17.0% 17.0% 17.0% 99.3% -

19.3 3.9 3.9 3.9 3.9 34.7 0.4 0.1 0.1 0.1 0.1 0.6 0.4 7.3 1.3 1.3 1.3 1.3 12.5 0.2 0.0 0.0

53.3% 10.7% 10.7% 10.7% 10.7% 96.0% -

17.5 17.5 0.4 0.4 0.2 -

Sub-Lease Income +4 Sub-Lease Income +5 Sub-Lease Income, Next 5 Yrs Contractual Obligations Due +1 Contractual Obligations Due, Next 5 Yrs Total Contractual Obligations Interest Rate Data W/Avg. Interest Rate - Long-term Debt Filing Date Currency Exchange Rate Conversion Method

0.2 13.5 13.5 13.5

0.0 0.0 0.2 11.4 11.4 11.4

5.4% Apr-14-2011 SGD 1.0 S

4.2% Apr-14-2011 SGD 1.0 S

May-13-2011 SGD 1.0 S

Financial data provided by

Summary

nths Mar-31-2011 % of Total 14.3% 85.7% 100.0%

nths Mar-31-2011 % of Total 3.7% 1.8% 5.5% 94.5% 100.0%

5.5% 53.9%

46.1% 3.7% 5.5% 3.7% 5.5% 5.5% -

53.9% 53.9% -

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Capital Structure Details
Principal Due in Millions of the reported currency. Period Type: Currency: Units: Annual Reported Currency Capital IQ (Default) Source: Conversion: Decimals: A 2010 filed Apr-14-2011 Today's Spot Rate Capital IQ (Default)

FY 2010 (Dec-31-2010) Capital Structure As Reported Details

Coupon/Base Description Bank Overdraft Finance Lease Liabilities Loan 1 from Bank Loan 10 from Bank Loan 2 from Bank Loan 3 from Bank Loan 4 from Bank Loan 5 from Bank Loan 6 from Bank Loan 7 from Bank Loan 8 from Bank Loan 9 from Bank Revolving Credit Facility Revolving Credit Facility Revolving Credit Facility Type Revolving Credit Capital Lease Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Revolving Credit Revolving Credit Revolving Credit Principal Due (SGD) 1.5 0.6 1.2 3.8 2.4 1.5 14.8 1.1 2.3 2.0 2.0 3.0 Rate 5.000% 2.800% - 11.200% 1.980% - 5.100% NA 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% NA NA NA NA Floating Rate NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Maturity Dec-31-2010 Dec-31-2014 2010 Mar-01-2014 2010 Dec-09-2014 Jan-01-2014 2010 Oct-26-2014 Jul-01-2012 Jun-01-2013 Jul-01-2013 Seniority Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior

FY 2009 (Dec-31-2009) Capital Structure As Reported Details

Coupon/Base Description Bank Overdraft Finance Lease Liabilities Loan 1 from Bank Loan 10 from Bank Loan 2 from Bank Loan 3 from Bank Loan 4 from Bank Loan 5 from Bank Loan 6 from Bank Loan 7 from Bank Loan 8 from Bank Loan 9 from Bank Revolving Credit Facility Revolving Credit Facility Revolving Credit Facility Type Revolving Credit Capital Lease Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Term Loans Revolving Credit Revolving Credit Revolving Credit Principal Due (SGD) 0.4 1.4 0.2 2.0 5.0 3.0 22.0 0.2 27.8 1.5 Rate 5.000% 2.800% - 11.200% 1.980% - 5.100% NA 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% 1.980% - 5.100% NA NA NA NA Floating Rate NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Maturity Dec-31-2010 Dec-31-2014 2010 Mar-01-2014 2010 Dec-09-2014 Jan-01-2014 2010 Oct-26-2014 Jul-01-2012 Jun-01-2013 Jul-01-2013 Seniority Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior Senior

Financial data provided by

tails

Repaymen Secured Yes Yes No No No No No Yes No Yes No No No No No Convertible No No No No No No No No No No No No No No No t Currency SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD

Repaymen Secured Yes Yes No No No No No Yes No Yes No No No No No Convertible No No No No No No No No No No No No No No No t Currency SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD SGD

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Ratios

Restatement: Order: Latest Filings Latest on Right Period Type: Decimals: Annual Capital IQ (Default)

Ratios For the Fiscal Period Ending Profitability Return on Assets % Return on Capital % Return on Equity % Return on Common Equity % Margin Analysis Gross Margin % EBITDA Margin % EBITA Margin % EBIT Margin % Earnings from Cont. Ops Margin % Net Income Margin % Net Income Avail. for Common Margin % Normalized Net Income Margin % Levered Free Cash Flow Margin % Unlevered Free Cash Flow Margin % Asset Turnover Total Asset Turnover Fixed Asset Turnover Accounts Receivable Turnover Inventory Turnover Short Term Liquidity Current Ratio Quick Ratio Cash from Ops. to Curr. Liab. Avg. Days Sales Out. Avg. Days Inventory Out. Avg. Days Payable Out. Avg. Cash Conversion Cycle Long Term Solvency 12 months Dec-31-2006 NA NA NA NA 12 months Dec-31-2007 6.4% 66.7% 154.7% 154.7% 12 months Dec-31-2008 5.0% 7.5% 13.5% 13.5% 12 months Dec-31-2009 5.3% 5.7% 10.7% 10.7% 12 months Dec-31-2010 1.3% 1.4% 1.7% 1.7%

25.7% 4.9% 3.6% 3.6% 4.9% 4.9% 4.9% 3.7% NA NA

32.6% 15.4% 14.5% 14.5% 13.1% 13.1% 13.1% 9.1% (2.0%) (1.7%)

34.1% 17.1% 16.1% 16.1% 11.8% 11.8% 11.8% 9.1% 11.2% 12.3%

33.2% 20.4% 19.4% 19.4% 15.5% 15.5% 15.5% 11.3% 10.5% 11.4%

19.9% 7.0% 5.6% 5.6% 3.3% 3.3% 3.3% 2.4% (8.8%) (7.7%)

NA NA NA NA

0.7x 18.8x 14.9x 17.0x

0.5x 22.6x 15.7x 18.3x

0.4x 21.3x 13.7x 18.7x

0.4x 14.7x 12.4x 20.7x

0.5x 0.4x 0.3x NA NA NA NA

1.4x 1.0x 0.4x 24.5 21.4 45.4 0.6

0.7x 0.7x 0.3x 23.3 20.0 39.4 3.8

1.2x 1.1x 0.4x 26.6 19.5 40.1 6.0

1.1x 0.9x NM 29.3 17.6 35.3 11.6

Total Debt/Equity Total Debt/Capital LT Debt/Equity LT Debt/Capital Total Liabilities/Total Assets EBIT / Interest Exp. EBITDA / Interest Exp. (EBITDA-CAPEX) / Interest Exp. Total Debt/EBITDA Net Debt/EBITDA Total Debt/(EBITDA-CAPEX) Net Debt/(EBITDA-CAPEX) Altman Z Score Growth Over Prior Year Total Revenue Gross Profit EBITDA EBITA EBIT Earnings from Cont. Ops. Net Income Normalized Net Income Diluted EPS before Extra Accounts Receivable Inventory Net PP&E Total Assets Tangible Book Value Common Equity Cash from Ops. Capital Expenditures Levered Free Cash Flow Unlevered Free Cash Flow Dividend per Share Compound Annual Growth Rate Over Two Years Total Revenue Gross Profit EBITDA EBITA EBIT

173.4% 63.4% NA NA 94.9% 15.4x 20.5x 0.9x 1.4x NM 32.0x NM 1.11

45.5% 31.3% 10.5% 7.2% 93.9% 31.4x 33.5x 30.3x 0.4x NM 0.5x NM 0.75

53.2% 34.7% 21.3% 13.9% 39.2% 9.6x 10.1x 8.9x 5.2x 3.0x 5.9x 3.4x 1.61

42.6% 29.9% 29.0% 20.4% 35.0% 12.8x 13.4x 12.9x 3.2x 1.6x 3.3x 1.7x 1.98

18.7% 15.8% 8.0% 6.7% 19.9% 3.2x 4.1x 0.6x 5.9x 2.6x 38.5x 16.6x 4.22

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

110.9% 168.0% 570.6% 738.3% 738.3% 469.3% 469.3% 420.1% 469.4% 88.3% 179.0% 87.9% 548.2% NM 683.3% 84.9% (32.2%) NA NA NA

89.0% 97.9% 109.6% 110.8% 110.8% 70.6% 70.6% 88.9% (99.7%) 73.9% 33.0% 40.9% 113.0% NM 2,008.2% 298.7% 161.5% NM NM NA

21.8% 18.4% 45.1% 46.8% 46.8% 59.5% 59.5% 50.8% (14.5%) 20.3% 12.4% 21.3% 3.1% NM 10.2% (22.2%) (52.8%) 14.2% 13.8% 100.0%

(12.2%) (47.4%) (69.7%) (74.9%) (74.9%) (81.4%) (81.4%) (81.5%) (85.4%) (22.8%) (20.6%) 31.4% 5.3% NM 29.6% NM 554.8% NM NM NA

NA NA NA NA NA

NA NA NA NA NA

99.7% 130.3% 274.9% 320.4% 320.4%

51.8% 53.1% 74.4% 75.9% 75.9%

3.4% (21.1%) (33.7%) (39.3%) (39.3%)

Earnings from Cont. Ops. Net Income Normalized Net Income Diluted EPS before Extra Accounts Receivable Inventory Net PP&E Total Assets Tangible Book Value Common Equity Cash from Ops. Capital Expenditures Levered Free Cash Flow Unlevered Free Cash Flow Dividend per Share Compound Annual Growth Rate Over Three Years Total Revenue Gross Profit EBITDA EBITA EBIT Earnings from Cont. Ops. Net Income Normalized Net Income Diluted EPS before Extra Accounts Receivable Inventory Net PP&E Total Assets Tangible Book Value Common Equity Cash from Ops. Capital Expenditures Levered Free Cash Flow Unlevered Free Cash Flow Dividend per Share Compound Annual Growth Rate Over Five Years Total Revenue Gross Profit EBITDA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

211.6% 211.6% 213.5% (86.3%) 80.9% 92.7% 62.7% 271.6% NM 1,185.0% 171.5% 33.2% NA NA NA

64.9% 64.9% 68.8% (94.7%) 44.6% 22.3% 30.8% 48.2% NM 382.0% 76.2% 11.1% NM NM NA

(45.5%) (45.5%) (47.2%) (64.6%) (3.6%) (5.5%) 26.2% 4.2% NM 19.5% NM 75.8% NM NM NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

69.4% 84.5% 173.2% 196.1% 196.1% 149.3% 149.3% 145.6% (74.8%) 57.9% 61.0% 47.6% 142.4% NM 466.7% 79.0% (5.8%) NA NA NA

26.4% 7.2% (2.7%) (8.1%) (8.1%) (20.3%) (20.3%) (19.2%) (92.6%) 17.3% 5.9% 31.0% 32.2% NM 211.1% NM 100.7% NM NM NA

NA NA NA

NA NA NA

NA NA NA

NA NA NA

NA NA NA

EBITA EBIT Earnings from Cont. Ops. Net Income Normalized Net Income Diluted EPS before Extra Accounts Receivable Inventory Net PP&E Total Assets Tangible Book Value Common Equity Cash from Ops. Capital Expenditures Levered Free Cash Flow Unlevered Free Cash Flow Dividend per Share

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Financial data provided by

LTM 12 months Mar-31-2011 1.3% 1.4% 1.6% 1.6%

20.6% 7.5% 6.0% 5.9% 3.5% 3.5% 3.5% 2.6% (5.3%) (4.3%)

0.3x 11.4x 4.8x 19.3x

1.1x 1.0x NM 76.0 18.9 56.6 38.3

16.7% 14.3% 7.7% 6.6% 18.0% 3.7x 4.6x 2.9x 5.1x 3.9x 8.1x 6.2x 4.76

(12.7%) (41.7%) (63.0%) (68.7%) (69.1%) (76.9%) (76.9%) (75.6%) (82.3%) 12.0% (17.4%) (16.5%) (4.2%) NM 15.9% NM (35.4%) NM NM NA

(2.1%) (24.4%) (38.2%) (43.5%) (43.8%)

(50.0%) (50.0%) (50.2%) (61.5%) 39.9% (6.5%) 26.1% 3.4% NM 18.3% NM 19.1% NA NA NA

17.7% 1.1% (8.1%) (13.0%) (13.3%) (24.0%) (24.0%) (22.3%) (93.0%) NA NA NA NA 38.4% 211.8% NM 40.7% NA NA NA

NA NA NA

NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Supplemental

In Millions of the reported currency, except per share items. Restatement:Latest Filings Currency: Reported Currency Order: Latest on Right Decimals: Capital IQ (Default)

Period Type: Annual Conversion: Today's Spot Rate Units: Capital IQ (Default)

Supplemental No Data Available

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Industry Specific
In Millions of the reported currency, except per share items. Restatement: Currency: Order: Decimals: Latest Filings Reported Currency Latest on Right Capital IQ (Default) Period Type: Conversion: Units: Annual Today's Spot Rate Capital IQ (Default)

Industry Specific For the Fiscal Period Ending Currency Facility Stats Consolidated Hospitals and Facilities Non-Consolidated Hospitals and Facilities Total Hospitals and Facilities Expenses as % of Revenue Salaries and Benefits Supplies Other Operating Expenses Other Items Net Patient Revenues Operating Expense - Supplies Filing Date

12 months Dec-31-2006 SGD -

12 months Dec-31-2007 SGD 80 0 80

12 months Dec-31-2008 SGD -

12 months Dec-31-2009 SGD -

12 months Dec-31-2010 SGD 87 0 87

52.2% 18.6% 20.6%

51.1% 14.1% 17.1%

45.0% 17.6% 17.0%

43.4% 19.2% 12.8%

58.2% 16.7% 12.8%

20.3 3.8 Jun-26-2008

42.8 6.0 Apr-20-2009

80.9 14.2 Apr-13-2010

98.6 19.0 Apr-14-2011

86.5 14.4 Apr-14-2011

Financial data provided by

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Pension/OPEB

In Millions of the reported currency, except per share items. Restatement: Currency: Order: Decimals: Latest Filings Reported Currency Latest on Right Capital IQ (Default) Period Type: Conversion: Units: Annual Today's Spot Rate Capital IQ (Default)

Pension/OPEB For the Fiscal Period Ending Currency Pension Information - Total Defined Benefit Net Periodic Cost Def. Contribution Plan Cost Total Pension Expense

12 months Dec-31-2006 SGD

12 months Dec-31-2007 SGD

12 months Dec-31-2008 SGD

12 months Dec-31-2009 SGD

12 months Dec-31-2010 SGD

0.7 0.7

0.5 0.5

2.0 2.0

2.2 2.2

2.5 2.5

Financial data provided by

Healthway Medical Corporation Limited (Catalist:5NG) > Financials > Segments

In Millions of the reported currency. View By: Period Type: Currency: Units: Line Items Annual Reported Currency Capital IQ (Default) Restatement: Order: Conversion: Decimals: Latest Filings Latest on Right Today's Spot Rate Capital IQ (Default)

Business Segments For the Fiscal Period Ending Currency Revenues Primary Healthcare Specialist and Wellness Healthcare Total Revenues Operating Profit Before Tax Primary Healthcare Total Operating Profit Before Tax Interest Expense Primary Healthcare Specialist and Wellness Healthcare Total Interest Expense Net Profit Before Tax Primary Healthcare Specialist and Wellness Healthcare Corporate Total Net Profit Before Tax Assets Primary Healthcare Specialist and Wellness Healthcare Corporate Total Assets Depreciation & Amortization Primary Healthcare Specialist and Wellness Healthcare Total Depreciation & Amortization 12 months Dec-31-2006 SGD 20.7 20.7 Reclassified 12 months Dec-31-2007 SGD 35.2 7.6 42.8 Reclassified 12 months Dec-31-2008 SGD 50.4 30.5 80.9 12 months Dec-31-2009 SGD 54.7 43.9 98.6 12 months Dec-31-2010 SGD 49.5 37.0 86.5

1.2 1.2

(0.6) (0.8) (1.4)

4.6 1.9 (0.2) 6.2

5.0 21.0 (14.2) 11.8

11.7 21.0 (15.0) 17.7

2.8 0.5 3.3

68.4 36.1 104.5

185.3 199.7 (162.4) 222.6

212.3 192.8 (175.5) 229.5

243.7 83.1 (85.2) 241.6

0.3 0.3

0.4 0.1 0.5

0.5 0.3 0.8

0.5 0.4 0.9

0.4 0.9 1.3

Capital Expenditure Primary Healthcare Specialist and Wellness Healthcare Total Capital Expenditure Filing Date

(1.0) (1.0) Jun-26-2008

(0.6) (0.2) (0.8) Apr-20-2009

(1.0) (0.7) (1.8) Apr-13-2010

(1.4) (0.5) (1.9) Apr-14-2011

(1.9) (4.7) (6.6) Apr-14-2011

Geographic Segments For the Fiscal Period Ending Currency Revenues Singapore China Total Revenues Interest Expense Singapore Total Interest Expense Net Profit Before Tax Singapore China Total Net Profit Before Tax Tax Expense Singapore Total Tax Expense Net Profit After Tax Singapore Total Net Profit After Tax Assets Singapore China Corporate Total Assets Depreciation & Amortization Singapore Total Depreciation & Amortization 12 months Dec-31-2006 SGD 20.7 20.7 Reclassified 12 months Dec-31-2007 SGD 43.2 43.2 Reclassified 12 months Dec-31-2008 SGD 80.9 80.9 12 months Dec-31-2009 SGD 98.6 98.6 12 months Dec-31-2010 SGD 81.7 4.8 86.5

0 0

(0.2) (0.2)

(1.4) (1.4)

1.2 1.2

6.2 6.2

11.8 11.8

17.7 17.7

2.3 1.0 3.3

0.2 0.2

0.6 0.6

2.3 2.3

1.0 1.0

5.6 5.6

9.6 9.6

104.5 104.5

222.6 222.6

229.5 229.5

267.5 59.3 (85.2) 241.6

0.3 0.3

0.4 0.4

0.8 0.8

Capital Expenditure Singapore Total Capital Expenditure Filing Date

(1.0) (1.0) Jun-26-2008

(0.7) (0.7) Apr-20-2009

(1.7) (1.7) Apr-13-2010

Apr-14-2011

Apr-14-2011

Financial data provided by